CIK 0001082554
- Large accelerated filer
UNITED THERAPEUTICS Corp
Sign in to watch- Ticker
- UTHR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 521984749
- Phone
- +1 301-608-9292
- Business address
- 1000 SPRING ST, SILVER SPRING, MD, 20910
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $344,206,005
- in 74 filings, $343.4M under 10b5-1 plans
Net −$344,206,005. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-11-03 | BENKOWITZ MICHAEL PRESIDENT AND COO | Sale 10b5-1 | −511 | $440.71 | $225K | 170 |
| 2025-11-03 | BENKOWITZ MICHAEL PRESIDENT AND COO | Sale 10b5-1 | −170 | $441.94 | $75K | 0 |
| 2025-11-03 | BENKOWITZ MICHAEL PRESIDENT AND COO | Exercise or conversion 10b5-1 | +7,875 | $146.03 | $1.1M | 7,875 |
| 2025-11-03 | BENKOWITZ MICHAEL PRESIDENT AND COO | Sale 10b5-1 | −7,875 | $417.50 | $3.3M | 0 |
| 2025-11-03 | BENKOWITZ MICHAEL PRESIDENT AND COO | Exercise or conversion · Stock Options 10b5-1 | −14,625 | 41,250 | ||
| 2025-11-03 | BENKOWITZ MICHAEL PRESIDENT AND COO | Exercise or conversion · Stock Options 10b5-1 | −7,875 | 10,500 | ||
| 2025-11-03 | CAUSEY CHRISTOPHER Director | Gift | −450 | 4,190 | ||
| 2025-11-03 | ROTHBLATT MARTINE A Chairperson & CEO | Exercise or conversion 10b5-1 | +4,000 | $120.26 | $481K | 4,130 |
| 2025-11-03 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,140 | $433.78 | $495K | 2,990 |
| 2025-11-03 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −360 | $434.33 | $156K | 2,630 |
| 2025-11-03 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,000 | $438.62 | $439K | 1,630 |
| 2025-11-03 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −500 | $441.39 | $221K | 1,130 |
| 2025-11-03 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,000 | $443.01 | $443K | 130 |
| 2025-11-03 | ROTHBLATT MARTINE A Chairperson & CEO | Exercise or conversion · Stock Option 10b5-1 | −4,000 | 130,000 | ||
| 2025-10-31 | ROTHBLATT MARTINE A Chairperson & CEO | Exercise or conversion 10b5-1 | +4,000 | $120.26 | $481K | 4,130 |
| 2025-10-31 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,000 | $447.83 | $448K | 3,130 |
| 2025-10-31 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −537 | $449.84 | $242K | 2,593 |
| 2025-10-31 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −2,463 | $451.49 | $1.1M | 130 |
| 2025-10-31 | ROTHBLATT MARTINE A Chairperson & CEO | Exercise or conversion · Stock Option 10b5-1 | −4,000 | 134,000 | ||
| 2025-10-30 | ROTHBLATT MARTINE A Chairperson & CEO | Exercise or conversion 10b5-1 | +4,000 | $120.26 | $481K | 4,130 |
Page 187 of 214 · 4,273 trades